References
- Centers for Disease Control and Prevention, National Center for Injury Prevention and Control, Division of Unintentional Injury Prevention. Opioid Data Analysis [Internet]; 2017 [cited 2017 Jul 30]. Available from: https://www.cdc.gov/drugoverdose/data/analysis.html
- Cicero TJ, Ellis MS, Surratt HL, et al. The changing face of heroin use in the United States: a retrospective analysis of the past 50 years. JAMA Psychiatry. 2014;71:821.
- Eggleston W, Marraffa JM, Stork CM, et al. Notes from the field: cardiac dysrhythmias after loperamide abuse - New York, 2008-2016. Morb Mortal Wkly Rep. 2016;65:1276–1277.
- Eggleston W, Clark KH, Marraffa JM. Loperamide abuse associated with cardiac dysrhythmia and death. Ann Emerg Med. 2017;69:83–86.
- Cinosi E, Martinotti G, Simonato P, et al. Following “the Roots” of Kratom (Mitragyna speciosa): the evolution of an enhancer from a traditional use to increase work and productivity in Southeast Asia to a recreational psychoactive drug in western countries. BioMed Res Int. 2015;2015:1–11.
- Quintana P, Ventura M, Grifell M, et al. The hidden web and the fentanyl problem: detection of ocfentanil as an adulterant in heroin. Int J Drug Policy. 2017;40:78–83.
- Zawilska JB. An expanding world of novel psychoactive substances: opioids. Front Psychiatry. 2017;8:110.
- Rudd RA, Aleshire N, Zibbell JE, et al. Increases in Drug and opioid overdose deaths-United States, 2000-2014. Morb Mortal Wkly Rep. 2016;64:1378–1382.
- Paone D, Nolan ML, Tuazon E, et al, Unintentional drug poisoning (overdose) deaths in New York City, 2000–2016. New York: New York City Department of Health and Mental Hygiene; 2017. (Epi Data Brief; 89).
- Slavova S, Costich JF, Bunn TL, et al. Heroin and fentanyl overdoses in Kentucky: epidemiology and surveillance. Int J Drug Policy. 2017;46:120–129.
- Katz J, Drug deaths in America are rising faster than ever [Internet]. New York: N. Y. Times; 2017 [cited 2017 Jul 31]. Available from: https://www.nytimes.com/interactive/2017/06/05/upshot/opioid-epidemic-drug-overdose-deaths-are-rising-faster-than-ever.html
- Palamar JJ, Su MK, Hoffman RS. Characteristics of novel psychoactive substance exposures reported to New York City Poison Center, 2011–2014. Am J Drug Alcohol Abuse. 2016;42:39–47.
- Australian Government Department of Health Therapeutic Goods (last). 3.6 Tianeptine [Internet]. Ther. Goods Adm. TGA; 2017 [cited 2017 Jul 18]. Available from: https://www.tga.gov.au/book-page/36-tianeptine
- Tianeptine Sulfate Powder [Internet]. Nootropics Depot; [cited 2017 Jul 18]. Available from: http://nootropicsdepot.com/tianeptine-sulfate-powder/
- Tianeptine Sodium Salt [Internet]. BlueBrainBoost; [cited 2017 Jul 18]. Available from: https://www.bluebrainboost.com/p/tianeptine/
- Gassaway MM, Rives M-L, Kruegel AC, et al. The atypical antidepressant and neurorestorative agent tianeptine is a μ-opioid receptor agonist. Transl Psychiatry. 2014;4:e411.
- Gupta S, Wallace R, Sloshower J. Online sales of unscheduled pharmaceutical agents: a case report of tianeptine use in the United States. J Addict Med. 2017;11:411–412.
- Proença P, Teixeira H, Pinheiro J, et al. Fatal intoxication with tianeptine (Stablon)®). Forensic Sci Int. 2007;170:200–203.
- Rouby F, Pradel V, Frauger E, et al. Assessment of abuse of tianeptine from a reimbursement database using “doctor-shopping” as an indicator: assessment of abuse liability of tianeptine. Fundam Clin Pharmacol. 2012;26:286–294.
- Vadachkoria D, Gabunia L, Gambashidze K, et al Addictive potential of tianeptine – the threatening reality. Georgian Med News. 2009;174:92–94.
- Sen A, Ilhan G, Tomak Y, et al. Role of cultural interaction in tianeptine abuse and different application methods. Turk J Anesth Reanim. 2013;41:229–231.
- Dempsey SK, Poklis JL, Sweat K, et al Acute toxicity from intravenous use of the tricyclic antidepressant tianeptine. J Anal Toxicol. 2017;41:547–550.
- Ari M, Oktar S, Duru M. Amitriptyline and tianeptine poisoning treated by naloxone. Hum Exp Toxicol. 2010;29:793–795.
- Bence C, Bonord A, Rebillard C, et al. Neonatal abstinence syndrome following tianeptine dependence during pregnancy. Pediatrics. 2016;137:e20151414.